Range
1.71 - 1.79
Vol / Avg.
2.8M/6.9M
Div / Yield
-
52 Wk
1.45 - 4.2
Mkt Cap
220.5M
Payout Ratio
-
Open
1.77
P/E
-
EPS
-0.2
Shares
128.2M
Outstanding
128.2M
Total Float
104.6M
Benzinga - May 28, 2021, 4:50PM
Benzinga - Apr 22, 2021, 2:05PM
load more
Sector: Health Care.Industry: Biotechnology
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipate providing contract filling, labeling and packing services.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.170-0.160 0.0100
REV14.580M16.049M1.469M
Q4 2020Est.ActualSurprise
EPS-0.160-0.210 -0.0500
REV12.910M13.956M1.046M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ADMAADMA Biologics-3.91%220.5M

ADMA Biologics Frequently Asked Questions

Q

How do I buy ADMA Biologics (ADMA) stock?

A

You can purchase shares of ADMA Biologics (NASDAQ: ADMA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ADMA Biologics's (ADMA) competitors?

Q

What is the target price for ADMA Biologics (ADMA) stock?

A

The latest price target for ADMA Biologics (NASDAQ: ADMA) was reported by Raymond James on March 26, 2021. The analyst firm set a price target for 6.00 expecting ADMA to rise to within 12 months (a possible 248.84% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ADMA Biologics (ADMA)?

A

The stock price for ADMA Biologics (NASDAQ: ADMA) is $1.72 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does ADMA Biologics (ADMA) pay a dividend?

A

There are no upcoming dividends for ADMA Biologics.

Q

When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?

A
ADMA Biologics’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is ADMA Biologics (ADMA) going to split?

A

There is no upcoming split for ADMA Biologics.

Q

What sector and industry does ADMA Biologics (ADMA) operate in?

A

ADMA Biologics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.